Skip to content

Clinical trials

Urinary Bladder, Overactive trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Country / region: Norway Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20072
20083
20091
20101
20112
20124
20132
20142
20161
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc7
Astellas Pharma Europe B.V.5
Pfizer5
Astellas Pharma Europe Ltd.2
Astellas Pharma Global Development, Inc.1
Oslo University Hospital1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
The Hospital of Vestfold1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive23
Urinary Incontinence10
Urinary Bladder Diseases3
Urinary Incontinence, Urge3
Urologic Diseases3
Nocturia2
Signs and Symptoms1
Spinal Cord Injuries1
Urological Manifestations1

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.